INTERNATIONAL PATENT: PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY FILES APPLICATION FOR "ENGINEERED IMMUNE SIGNALING CONSTRUCTS"

GENEVA, June 12 -- PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (1 Letterman Drive, Suite D3500San Francisco, California 94129) filed a patent application (PCT/US2024/057810) for "ENGINEERED IMMUNE SIGNALING CONSTRUCTS" on Nov 27, 2024. With publication no. WO/2025/117789, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CONNOLLY, John (1 Letterman Drive, Suite D3500San Francisco, California 94129)

Abstract: Disclosed herein are engineered immune signaling constructs that can comprise, for example, an extracellular region,...